Stock Events

Hikma Pharmaceuticals 

€22.4
2
-€0.4-1.75% Today

Statistics

Day High
22.4
Day Low
22.4
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
5.35B
P/E Ratio
30.63
Dividend Yield
2.92%
Dividend
0.65

Upcoming

Dividends

2.92%Dividend Yield
10Y Growth
15.64%
5Y Growth
12.68%
3Y Growth
14.81%
1Y Growth
15.6%

Earnings

21FebExpected
Q4 2020
Q2 2021
Q4 2021
Q2 2022
Q4 2022
Q2 2023
Q4 2023
-1.22
-0.49
0.25
0.98
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow H5P.F. It's not an investment recommendation.

About

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms in North America, the Middle East, North Africa, and Europe. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company was founded in 1978 and is headquartered in London, the United Kingdom.
Show more...
CEO
Engineer Said Samih Taleb Darwazah
Employees
9100
Country
GB
ISIN
GB00B0LCW083
WKN
000A0HG69

Listings